Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 20/4/2018
SIETES contiene 92261 citas

 
 
 1 a 20 de 27 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Go AS, Singer DE, Toh S, Cheetham TC, Reichman ME, Graham DJ, Southworth MR, Zhang R, Izem R, Goulding MR, Houstoun M, Mott K, Sung SH, Gagne JJ. Outcomes of dabigatran and warfarin for atrial fibrillation in contemporary practice: a retrospective cohort study. Ann Intern Med 2017;167:845-54. [Ref.ID 102196]
2.Enlace a cita originalTiene citas relacionadas
Gurwitz JH, Go AS, Fortmann SP. Statins for primary prevention in older adults: uncertainty and the need for more evidence. JAMA 2016;316:1971-2. [Ref.ID 100985]
3. Cita con resumen
Hlatky MA, Solomon MD, Shilane D, Leong TK, Brindis R, Go AS. Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary intervention. J Am Coll Cardiol 2013;61:295-301. [Ref.ID 94639]
5.Tiene citas relacionadas Cita con resumen
Habel LA, Cooper WO, Sox CM, Chan KA, Fireman BH, Arbogast PG, Cheetham C, Quinn VP, Dublin S, Boudreau DM, Andrade SE, Pawloski PA, Raebel MA, Smith DH, Achacoso N, Uratsu C, Go AS, Sidney S, Nguyen-Huynh MN. ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA 2011;306:2673-83. [Ref.ID 91839]
6. Cita con resumen
Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, Singer DE. New risk scheme to predict warfarin-associated hemorrhage. The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study . J Am Coll Cardiol 2011;58:395-401. [Ref.ID 91253]
7. Cita con resumen
Freeman JV, Zhu RP, Owens DK, Garber AM, Hutton DW, Go AS, Wang PJ, Turakhia MP. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Ann Intern Med 2011;154:1-11. [Ref.ID 90077]
8.Tiene citas relacionadas
Singer DE, Fang MC, Go AS. The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation. Arch Intern Med 2009;169:2032. [Ref.ID 87129]
9.Tiene citas relacionadas Cita con resumen
Singer DE, Chang Y, Fang MC, Borowsky LH, Pomernacki NK, Udaltsova N, Go AS. The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med 2009;151:297-305. [Ref.ID 86705]
10.Tiene citas relacionadas Cita con resumen
Go AS. The ACTIVE pursuit of stroke prevention in patients with atrial fibrillation. N Engl J Med 2009;360:2127-9. [Ref.ID 85836]
11.Tiene citas relacionadas Cita con resumen
Go AS, Yang J, Gurwitz JH, Hsu J, Lane K, Platt R. Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice. Arch Intern Med 2008;168:2415-21. [Ref.ID 84728]
12.Tiene citas relacionadas
Go AS, Singer DE. Stroke prevention in atrial fibrillation: another step sideways. Lancet 2008;371:278-80. [Ref.ID 82042]
13.Tiene citas relacionadas
Go AS, Gurwitz JH. Statin use and risks for death and hospitalization in chronic heart failure. In reply. JAMA 2007;297:1058. [Ref.ID 79599]
14.Tiene citas relacionadas
Go AS, Ayus JC. Chronic kidney disease, anemia, and epoetin. N Engl J Med 2007;356:957. [Ref.ID 79386]
15. Cita con resumen
Go AS, Lee WY, Yang J, Lo JC, Gurwitz JH. Statin therapy and risks for death and hospitalization in chronic heart failure. JAMA 2006;296:2105-11. [Ref.ID 78498]
16. Cita con resumen
Fang MC, Go AS, Chang Y, Hylek EM, Henault LE, Jensvold NG, Singer DE. Death and disability from warfarin-associated intracranial and extracranial hemorrhages. The American Journal of Medicine 2007;120:700-5. [Ref.ID 78282]
17.Tiene citas relacionadas Cita con resumen
Go AS, Iribarren C, Chandra M, Lathon PV, Fortmann SP, Quertermous T, Hlatky MA, for the Atherosclerotic Disease Vascular Function and Genetic Epidemiology (ADVANCE) Study. Statin and beta-blocker therapy and the initial presentation of coronary heart disease. Ann Intern Med 2006;144:229-38. [Ref.ID 76452]
18. Cita con resumen
Fang MC, Chang Y, Hylek EM, Rosand J, Greenberg SM, Go AS, Singer DE. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med 2004;141:745-52. [Ref.ID 71979]
19.Tiene citas relacionadas
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-305. [Ref.ID 71433]
20. Cita con resumen
Go AS, Hylek EM, Chang Y, Phillips K A, Henault LE, Capra AM, Jensvold NG, Selby JV, Singer DE. Anticoagulation therapy for stroke prevention in atrial fibrillation. How well do randomized trials translate into clinical practice?. JAMA 2003;290:2685-92. [Ref.ID 68223]
Seleccionar todas
 
 1 a 20 de 27 siguiente >>